Oncbiomune

Developing novel cancer immunotherapy products with a proprietary vaccine technology

placeBaton Rouge, Louisiana, United States calendar_todayFounded 2005 groups16 employees language oncbiomune.com

Registered entities

Investor mix

1 investor on record.

Investor typeCountShare
Private equity1100%
Coming soon